Squarepoint’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-28,005
| Closed | -$169K | – | 2744 |
|
|
2019
Q4 | $169K | Sell |
28,005
-244,460
| -90% | -$1.48M | ﹤0.01% | 2167 |
|
|
2019
Q3 | $981K | Buy |
272,465
+141,297
| +108% | +$509K | 0.01% | 1215 |
|
|
2019
Q2 | $352K | Buy |
131,168
+89,761
| +217% | +$241K | ﹤0.01% | 1803 |
|
|
2019
Q1 | $123K | Sell |
41,407
-10,921
| -21% | -$32.4K | ﹤0.01% | 1962 |
|
|
2018
Q4 | $83K | Sell |
52,328
-319,329
| -86% | -$507K | ﹤0.01% | 1801 |
|
|
2018
Q3 | $1.37M | Buy |
371,657
+148,972
| +67% | +$548K | 0.02% | 852 |
|
|
2018
Q2 | $630K | Buy |
+222,685
| New | +$630K | 0.01% | 1082 |
|
|
2018
Q1 | – | Sell |
-232,146
| Closed | -$669K | – | 2367 |
|
|
2017
Q4 | $669K | Buy |
232,146
+183,895
| +381% | +$530K | 0.01% | 1010 |
|
|
2017
Q3 | $217K | Buy |
+48,251
| New | +$217K | ﹤0.01% | 1331 |
|
|
2017
Q2 | – | Sell |
-58,268
| Closed | -$245K | – | 1937 |
|
|
2017
Q1 | $245K | Sell |
58,268
-94,557
| -62% | -$398K | 0.01% | 1182 |
|
|
2016
Q4 | $631K | Buy |
152,825
+117,825
| +337% | +$486K | 0.03% | 708 |
|
|
2016
Q3 | $284K | Sell |
35,000
-21,400
| -38% | -$174K | 0.02% | 753 |
|
|
2016
Q2 | $440K | Buy |
56,400
+27,300
| +94% | +$213K | 0.03% | 599 |
|
|
2016
Q1 | $225K | Sell |
29,100
-41,700
| -59% | -$322K | 0.02% | 957 |
|
|
2015
Q4 | $764K | Buy |
+70,800
| New | +$764K | 0.08% | 347 |
|